Arthur Dunk CHT(ACHI)

Director/President

I'm passionate about my faith and helping people live their best life. I have a deep understanding of immunogenetics and the challenges of living with rare genetics.

About

Arthur is passionate about helping people.

Experience

Arthur Dunk is a dedicated researcher in the field of immunogenetics, with a particular focus on HLA haplotypes. His valuable contributions have been recognized in various scientific studies, including his notable involvement in the groundbreaking research titled "P072NGS characterization of extended HLA haplotypes in Jamaican families from the Caribbean Bone Marrow Registry: A study of the 17th International HLA & Immunogenetics Workshop."

In this study, Arthur Dunk collaborated with esteemed experts and researchers to investigate the intricate details of HLA haplotype segregation within Jamaican families. Their findings shed light on the unique genetic diversity present in the Jamaican population, emphasizing the importance of establishing a local/regional Bone Marrow Transplant (BMT) registry to enhance the chances of finding suitable donors.

Arthur Dunk's expertise lies in utilizing advanced NGS HLA genotyping techniques and bioinformatics tools to analyze and identify haplotypes accurately. Despite encountering challenges with DNA quality during the research, his perseverance and meticulous approach led to successful typing of all individuals involved.

His work stands out for its significant impact on haplotype associations among populations with limited typing data, where traditional bioinformatics algorithms may be less reliable. Arthur's dedication to understanding the complexities of HLA haplotypes paves the way for improved personalized medicine, transplantation outcomes, and better patient care.

With a passion for cutting-edge research and a commitment to scientific excellence, Arthur Dunk continues to contribute invaluable insights to the field of immunogenetics. His work serves as an inspiration to fellow researchers and underscores the importance of genetic studies in advancing medical knowledge and improving patient outcomes.

Expertise

Arthur is licensed by the American Board of Histocompatibility and Immunogenetics (CHT)

Treatment

Category

team members holding puzzle pieces and putting them together